Richard Cunningham
Chief Executive Officer at TYME TECHNOLOGIES, INC.
Profile
Mr. Richard A.
Cunningham is a Chief Executive Officer & Director at Anebulo Pharmaceuticals, Inc., a Chief Executive Officer at Tyme Technologies, Inc. and a President, Chief Executive Officer & Director at Icagen-T, Inc. He is on the Board of Directors at Anebulo Pharmaceuticals, Inc., Tyme Technologies, Inc. and Icagen-T, Inc. Mr. Cunningham was previously employed as a President, Chief Executive Officer & Director by Icagen, Inc.
Richard Cunningham active positions
| Companies | Position | Start |
|---|---|---|
| TYME TECHNOLOGIES, INC. | Chief Executive Officer | 2020-11-23 |
| ANEBULO PHARMACEUTICALS, INC. | Chief Executive Officer | 2023-10-04 |
Icagen-T, Inc.
 Icagen-T, Inc. BiotechnologyHealth Technology Icagen-T, Inc. engages in development of pharmaceutical drugs. The company is headquartered in Oro Valley, AZ. | Chief Executive Officer | - |
Former positions of Richard Cunningham
| Companies | Position | End |
|---|---|---|
Icagen, Inc.
 Icagen, Inc. Medical SpecialtiesHealth Technology Icagen, Inc. engages in the development of pharmaceutical and drug discovery instruments. It offers chemistry, biology, and ion channels and transporters. The company was founded by Benjamin P. Warner and Frank Jeremiel Zimmerman in 1992 and is headquartered in Durham, NC. | Chief Executive Officer | 2020-10-31 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ANEBULO PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Icagen, Inc.
Icagen, Inc. Medical SpecialtiesHealth Technology Icagen, Inc. engages in the development of pharmaceutical and drug discovery instruments. It offers chemistry, biology, and ion channels and transporters. The company was founded by Benjamin P. Warner and Frank Jeremiel Zimmerman in 1992 and is headquartered in Durham, NC. | Health Technology |
Icagen-T, Inc.
Icagen-T, Inc. BiotechnologyHealth Technology Icagen-T, Inc. engages in development of pharmaceutical drugs. The company is headquartered in Oro Valley, AZ. | Health Technology |
Tyme Technologies, Inc.
 Tyme Technologies, Inc. Pharmaceuticals: MajorHealth Technology Tyme Technologies, Inc. operates as a biotechnology company, which engages in the development and commercialization of cancer therapies. It offers a clinical program named SM-88 which is a novel, oral, and monotherapy investigational agent that aims to disrupt the cancer cell's protein synthesis. The company was founded by Steve Hoffman and Michael Demurjian on November 22, 2011 and is headquartered in Bedminster, NJ. | Health Technology |
- Stock Market
- Insiders
- Richard Cunningham
